Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf M Huber

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Nuklearmedizin. Nuclear Medicine|April 22, 2017
Cancer vaccination causes prolonged FDG accumulation in subcutaneous tissueKathrin Kahnert, Diego Kauffmann-Guerrero, Amanda Tufman, et al.
International Archives of Allergy and Immunology|November 16, 2006
IL-13Ralpha2 reverses the effects of IL-13 and IL-4 on bronchial reactivity and acetylcholine-induced Ca+ signalingJulia Kellner, Fernando Gamarra, Ulrich Welsch, et al.
American Journal of Respiratory Cell and Molecular Biology|February 28, 2004
MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway SecretionsMarkus O Henke, Armin Renner, Rudolf M Huber, et al.
Onkologie|June 5, 2010
[Current developments and perspectives in targeted therapies]Nicolas Dickgreber, Rudolf M Huber, Martin Reck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy GroupRudolf M Huber, Michael Flentje, Michael Schmidt, et al.
La Radiologia Medica|May 8, 2016
Thoracic lymph node delineation at dose-reduced (1 mSv) dose-modulated contrast enhanced MDCT: a retrospective pilot studyMarco Paolini, Kathrin Wirth, Amanda Tufman, et al.
Onkologie|September 16, 2006
[Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV]Karl-Matthias Deppermann, Rudolf M Huber, Eckart Laack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2016
Pathway Targeted Immunotherapy: Rationale and Evidence of Durable Clinical Responses with a Novel, EGF-directed Agent for Advanced NSCLCRafael Rosell, Elia Neninger, Marianne Nicolson, et al.
Radiation Oncology (London, England)|January 8, 2013
Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumorsOlivier M Niemoeller, Barbara Pöllinger, Maximilian Niyazi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Cystic fibrosis diagnosed in a 38-year-old man with long-standing HIV infectionHans X Hoyer, Holger Schmid, Fernando Gamarra, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Nuklearmedizin. Nuclear Medicine|April 22, 2017
Cancer vaccination causes prolonged FDG accumulation in subcutaneous tissueKathrin Kahnert, Diego Kauffmann-Guerrero, Amanda Tufman, et al.
International Archives of Allergy and Immunology|November 16, 2006
IL-13Ralpha2 reverses the effects of IL-13 and IL-4 on bronchial reactivity and acetylcholine-induced Ca+ signalingJulia Kellner, Fernando Gamarra, Ulrich Welsch, et al.
American Journal of Respiratory Cell and Molecular Biology|February 28, 2004
MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway SecretionsMarkus O Henke, Armin Renner, Rudolf M Huber, et al.
Onkologie|June 5, 2010
[Current developments and perspectives in targeted therapies]Nicolas Dickgreber, Rudolf M Huber, Martin Reck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy GroupRudolf M Huber, Michael Flentje, Michael Schmidt, et al.
La Radiologia Medica|May 8, 2016
Thoracic lymph node delineation at dose-reduced (1 mSv) dose-modulated contrast enhanced MDCT: a retrospective pilot studyMarco Paolini, Kathrin Wirth, Amanda Tufman, et al.
Onkologie|September 16, 2006
[Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV]Karl-Matthias Deppermann, Rudolf M Huber, Eckart Laack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2016
Pathway Targeted Immunotherapy: Rationale and Evidence of Durable Clinical Responses with a Novel, EGF-directed Agent for Advanced NSCLCRafael Rosell, Elia Neninger, Marianne Nicolson, et al.
Radiation Oncology (London, England)|January 8, 2013
Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumorsOlivier M Niemoeller, Barbara Pöllinger, Maximilian Niyazi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Cystic fibrosis diagnosed in a 38-year-old man with long-standing HIV infectionHans X Hoyer, Holger Schmid, Fernando Gamarra, et al.
Pageof 11